TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway

Cell Biology International
Liyin LiCuixia Bao

Abstract

Tripartite motif-containing 22 (TRIM22) is reported to participate in numerous cellular activities. Recent studies confirm that TRIM22 is a target gene for P53, and inhibits clonogenic growth of leukemic U-937 cells. The current study aims to discover the effect of TRIM22 in progression of human chronic myeloid leukemia (CML) and explore the related mechanism. TRIM22 was knocked down by siRNA transfection in CML cell K562. We observed that TRIM22 knockdown decreased proliferation and invasion in K562 cells. TRIM22 knockdown significantly induced cell cycle arrest by regulating the level of CDK4, Cyclin D1, P70S6K, and P53 in K562 cell. Moreover, loss of TRIM22 also promoted apoptosis through modulation of Bcl-2, Bax and active Caspase 3 in K562 cell. Furthermore, we demonstrated that TRIM22 knockdown inhibited the activation of PI3K/Akt/mTOR pathway by decreasing the level of the phosphorylated form p-Akt and p-mTOR in K562 cell. In conclusion, loss of TRIM22 suppresses the progression and invasion of CML through regulation of PI3K/Akt/mTOR pathway, suggesting that TRIM22 might be as a potential target for the treatment strategy of CML.

References

Jul 1, 1995·Stem Cells·F Lanza, S Bi
May 11, 2002·Nature Reviews. Cancer·Frederik H Igney, Peter H Krammer
Mar 17, 2004·Cancer Treatment Reviews·Juan Angel Fresno VaraManuel González-Barón
Oct 27, 2004·Apoptosis : an International Journal on Programmed Cell Death·M OsakiH Ito
Sep 22, 2005·Nature Reviews. Microbiology·Sébastien NisoleAli Saïb
Nov 16, 2005·International Journal of Cancer. Journal International Du Cancer·B ZirnM Gessler
Apr 5, 2008·PLoS Pathogens·Stephen D BarrFrederic D Bushman
Oct 29, 2010·Journal of Virology·Ravesh SinghUNKNOWN CAPRISA Acute Infection Study Team
Jul 19, 2011·Developmental Cell·Jean-Claude Martinou, Richard J Youle
Feb 15, 2013·Journal of Virology·Andrea Di PietroElisa Vicenzi
Jun 5, 2013·Cold Spring Harbor Perspectives in Biology·Amanda B ParrishSally Kornbluth
Nov 5, 2013·Biochemical and Biophysical Research Communications·Yang SunValerie C-L Lin
Feb 17, 2015·Cellular & Molecular Immunology·Chen YangBing Sun
Apr 29, 2015·Expert Review of Hematology·Jane HuangJohn C Reed
Nov 18, 2015·Cancer Research·Xuyi WangKristy A Brown

❮ Previous
Next ❯

Citations

Apr 13, 2019·International Journal of Molecular Sciences·Alessio VallettiApollonia Tullo
Apr 26, 2020·Molecular Biology Reports·Ningni JiangJuan Peng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.